JPS4826764A - - Google Patents

Info

Publication number
JPS4826764A
JPS4826764A JP47079557A JP7955772A JPS4826764A JP S4826764 A JPS4826764 A JP S4826764A JP 47079557 A JP47079557 A JP 47079557A JP 7955772 A JP7955772 A JP 7955772A JP S4826764 A JPS4826764 A JP S4826764A
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP47079557A
Other languages
Japanese (ja)
Other versions
JPS5652001B2 (OSRAM
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36763080&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=JPS4826764(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed filed Critical
Publication of JPS4826764A publication Critical patent/JPS4826764A/ja
Publication of JPS5652001B2 publication Critical patent/JPS5652001B2/ja
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Otolaryngology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP7955772A 1971-08-10 1972-08-10 Expired JPS5652001B2 (OSRAM)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB3745671A GB1410588A (en) 1971-08-10 1971-08-10 Composition
DK392872A DK131891C (da) 1971-08-10 1972-08-09 Fremgangsmade til fremstilling af et pulverpreparat til inhalation
ZA730284A ZA73284B (en) 1971-08-10 1973-01-15 Pharmaceutical powder composition containing sodium cromoglycate
AU51191/73A AU5119173A (en) 1971-08-10 1973-01-17 Composition
ES410910A ES410910A1 (es) 1971-08-10 1973-01-24 Un procedimiento para la preparacion de una composicion farmaceutica en polvo para inhalacion.

Publications (2)

Publication Number Publication Date
JPS4826764A true JPS4826764A (OSRAM) 1973-04-09
JPS5652001B2 JPS5652001B2 (OSRAM) 1981-12-09

Family

ID=36763080

Family Applications (1)

Application Number Title Priority Date Filing Date
JP7955772A Expired JPS5652001B2 (OSRAM) 1971-08-10 1972-08-10

Country Status (19)

Country Link
US (1) US4009280A (OSRAM)
JP (1) JPS5652001B2 (OSRAM)
AT (1) AT333974B (OSRAM)
AU (1) AU5119173A (OSRAM)
CA (1) CA992461A (OSRAM)
DE (1) DE2239091A1 (OSRAM)
DK (2) DK131891C (OSRAM)
ES (1) ES410910A1 (OSRAM)
FI (1) FI56487C (OSRAM)
FR (1) FR2150759B1 (OSRAM)
GB (1) GB1410588A (OSRAM)
IE (1) IE37102B1 (OSRAM)
IL (1) IL39990A (OSRAM)
LU (1) LU66875A1 (OSRAM)
NL (1) NL7210780A (OSRAM)
NO (1) NO140747C (OSRAM)
SE (1) SE411842B (OSRAM)
ZA (1) ZA73284B (OSRAM)
ZM (1) ZM11971A1 (OSRAM)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5042819A (OSRAM) * 1973-08-20 1975-04-18
JPS5042827A (OSRAM) * 1973-08-20 1975-04-18
JPS5042826A (OSRAM) * 1973-08-20 1975-04-18
JPS5271212A (en) * 1975-12-11 1977-06-14 Sony Corp Magnetic playback apparatus
JPS5313111U (OSRAM) * 1976-07-16 1978-02-03
JPS57106613A (en) * 1980-11-05 1982-07-02 Fisons Ltd Pharmacetical medicine

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4238502A (en) * 1978-08-03 1980-12-09 Fisons Limited Method of treating psychiatric conditions
DE3636209A1 (de) * 1986-10-24 1988-04-28 Lentia Gmbh Verfahren zur herstellung eines bindemittelfreien tablettierfaehigen celiprololhydrochlorid-granulates
DE4140689B4 (de) * 1991-12-10 2007-11-22 Boehringer Ingelheim Kg Inhalationspulver und Verfahren zu ihrer Herstellung
GB9322014D0 (en) 1993-10-26 1993-12-15 Co Ordinated Drug Dev Improvements in and relating to carrier particles for use in dry powder inhalers
GB9404945D0 (en) 1994-03-15 1994-04-27 Glaxo Group Ltd Pharmaceutical composition
DE4425255A1 (de) 1994-07-16 1996-01-18 Asta Medica Ag Formulierung zur inhalativen Applikation
GB9501841D0 (en) * 1995-01-31 1995-03-22 Co Ordinated Drug Dev Improvements in and relating to carrier particles for use in dry powder inhalers
US5747002A (en) * 1995-04-05 1998-05-05 Genentech, Inc. Preparation of sodium chloride aerosol formulations
US5985309A (en) * 1996-05-24 1999-11-16 Massachusetts Institute Of Technology Preparation of particles for inhalation
US5874064A (en) * 1996-05-24 1999-02-23 Massachusetts Institute Of Technology Aerodynamically light particles for pulmonary drug delivery
US20020052310A1 (en) * 1997-09-15 2002-05-02 Massachusetts Institute Of Technology The Penn State Research Foundation Particles for inhalation having sustained release properties
US6652837B1 (en) 1996-05-24 2003-11-25 Massachusetts Institute Of Technology Preparation of novel particles for inhalation
US7052678B2 (en) 1997-09-15 2006-05-30 Massachusetts Institute Of Technology Particles for inhalation having sustained release properties
JP4526702B2 (ja) † 1997-09-29 2010-08-18 ネクター セラピューティックス 安定化生物活性処方物およびその使用方法
US6309623B1 (en) * 1997-09-29 2001-10-30 Inhale Therapeutic Systems, Inc. Stabilized preparations for use in metered dose inhalers
US20060165606A1 (en) * 1997-09-29 2006-07-27 Nektar Therapeutics Pulmonary delivery particles comprising water insoluble or crystalline active agents
US6565885B1 (en) 1997-09-29 2003-05-20 Inhale Therapeutic Systems, Inc. Methods of spray drying pharmaceutical compositions
US6956021B1 (en) 1998-08-25 2005-10-18 Advanced Inhalation Research, Inc. Stable spray-dried protein formulations
CA2382821A1 (en) * 1999-08-25 2001-03-01 Advanced Inhalation Research, Inc. Modulation of release from dry powder formulations
US20010036481A1 (en) * 1999-08-25 2001-11-01 Advanced Inhalation Research, Inc. Modulation of release from dry powder formulations
US7678364B2 (en) 1999-08-25 2010-03-16 Alkermes, Inc. Particles for inhalation having sustained release properties
US6749835B1 (en) 1999-08-25 2004-06-15 Advanced Inhalation Research, Inc. Formulation for spray-drying large porous particles
US8404217B2 (en) * 2000-05-10 2013-03-26 Novartis Ag Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use
PT1280520E (pt) 2000-05-10 2014-12-16 Novartis Ag Pós à base de fosfolípidos para administração de fármacos
US7871598B1 (en) * 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
AU2001280934A1 (en) * 2000-07-28 2002-02-13 Alliance Pharmaceutical Corp. Methods and compositions to upregulate, redirect or limit immune responses to bioactive compounds
EP1345629A2 (en) * 2000-12-29 2003-09-24 Advanced Inhalation Research, Inc. Particles for inhalation having sustained release properties
US20020141946A1 (en) * 2000-12-29 2002-10-03 Advanced Inhalation Research, Inc. Particles for inhalation having rapid release properties
BR0207062A (pt) * 2001-02-06 2004-10-05 Innovata Biomed Ltd Composição farmacêutica bimodal, inalador para pó seco, método de aplicação de uma quantidade terapeuticamente eficaz de um ingrediente ativo substancialmente fino aos pulmões de um paciente, método de tratamento de um distúrbio respiratório, método de tratamento de doença pulmonar obstrutiva crÈnica (copd), uso de um agente antiinflamatório, uso de um broncodilatador, uso de uma mistura de um agente antiinflamatório e de um broncodilatador, e, processo para a fabricação de uma composição farmacêutica bimodal
EP1455755B1 (en) * 2001-11-20 2013-04-17 Civitas Therapeutics, Inc. Improved particulate compositions for pulmonary delivery
US20030129250A1 (en) * 2001-11-20 2003-07-10 Advanced Inhalation Research Inc. Particulate compositions for improving solubility of poorly soluble agents
ES2364636T3 (es) * 2001-12-19 2011-09-08 Novartis Ag Administración pulmonar de aminoglucósidos.
US6889690B2 (en) * 2002-05-10 2005-05-10 Oriel Therapeutics, Inc. Dry powder inhalers, related blister devices, and associated methods of dispensing dry powder substances and fabricating blister packages
US7763280B2 (en) * 2002-11-28 2010-07-27 Boehringer Ingelheim Pharma Gmbh & Co. Kg Tiotropium containing powder formulation for inhalation
US20070031342A1 (en) * 2005-06-22 2007-02-08 Nektar Therapeutics Sustained release microparticles for pulmonary delivery
KR101657029B1 (ko) * 2008-07-24 2016-09-12 레르 리키드 쏘시에떼 아노님 뿌르 레드 에렉스뿔라따시옹 데 프로세데 조르즈 클로드 전이 금속 함유 필름의 침착을 위한 헤테로렙틱 시클로펜타디에닐 전이 금속 전구체

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3121096A (en) * 1961-12-27 1964-02-11 Roussel Uclaf New process of preparation of 3-methyl chromone
GB1144905A (en) * 1965-03-25 1969-03-12 Fisons Pharmaceuticals Ltd Substituted bis-(2-carboxy-chromonyl-oxy) derivatives and preparation and pharmaceutical compositions thereof
US3686412A (en) * 1965-03-25 1972-08-22 Colin Fitzmaurice Compositions containing bis-chromonyl compounds for inhibiting antigen-antibody reactions
GB1147976A (en) * 1965-12-21 1969-04-10 Fisons Pharmaceuticals Ltd Chromone derivatives
GB1190193A (en) * 1966-07-05 1970-04-29 Fisons Pharmaceuticals Ltd Bis-(2-Carboxy-Chromonyl-Oxy) Derivatives, their preparation, and Pharmaceutical Compositions thereof
GB1242211A (en) * 1967-08-08 1971-08-11 Fisons Pharmaceuticals Ltd Pharmaceutical composition
GB1223690A (en) * 1967-10-17 1971-03-03 Fisons Pharmaceuticals Ltd Substituted chromon-2-carboxylic acids
GB1292601A (en) * 1968-10-30 1972-10-11 Fisons Pharmaceuticals Ltd Bis-(2-carboxy-chromone) compounds, their preparation and pharmaceutical compositions containing them

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5042819A (OSRAM) * 1973-08-20 1975-04-18
JPS5042827A (OSRAM) * 1973-08-20 1975-04-18
JPS5042826A (OSRAM) * 1973-08-20 1975-04-18
JPS5271212A (en) * 1975-12-11 1977-06-14 Sony Corp Magnetic playback apparatus
JPS5313111U (OSRAM) * 1976-07-16 1978-02-03
JPS57106613A (en) * 1980-11-05 1982-07-02 Fisons Ltd Pharmacetical medicine

Also Published As

Publication number Publication date
ZA73284B (en) 1973-11-28
NL7210780A (OSRAM) 1973-02-13
ES410910A1 (es) 1976-07-16
GB1410588A (en) 1975-10-22
FR2150759B1 (OSRAM) 1975-10-31
NO140747B (no) 1979-07-30
DK535774A (OSRAM) 1975-06-02
DK146974B (da) 1984-03-05
AU5119173A (en) 1974-07-18
FR2150759A1 (OSRAM) 1973-04-13
JPS5652001B2 (OSRAM) 1981-12-09
SE411842B (sv) 1980-02-11
ATA39073A (de) 1976-04-15
IE37102B1 (en) 1977-05-11
IL39990A0 (en) 1972-09-28
LU66875A1 (OSRAM) 1973-03-23
DK131891C (da) 1976-02-23
DK146974C (da) 1984-08-13
DE2239091A1 (de) 1973-02-22
DK131891B (da) 1975-09-22
CA992461A (en) 1976-07-06
IL39990A (en) 1977-02-28
NO140747C (no) 1979-11-07
AT333974B (de) 1976-12-27
FI56487C (fi) 1980-02-11
FI56487B (fi) 1979-10-31
US4009280A (en) 1977-02-22
ZM11971A1 (en) 1973-02-21

Similar Documents

Publication Publication Date Title
FR2150759B1 (OSRAM)
ATA136472A (OSRAM)
AR196074A1 (OSRAM)
AU2691671A (OSRAM)
AU465401B2 (OSRAM)
AU2485671A (OSRAM)
AU3005371A (OSRAM)
AU2564071A (OSRAM)
AU2952271A (OSRAM)
AU2588771A (OSRAM)
AU2503871A (OSRAM)
AR202997Q (OSRAM)
AU2654071A (OSRAM)
AR192311Q (OSRAM)
AU2577671A (OSRAM)
AU1109576A (OSRAM)
AU2399971A (OSRAM)
AU2963771A (OSRAM)
AR199640Q (OSRAM)
AU2415871A (OSRAM)
AU2455871A (OSRAM)
AU3025871A (OSRAM)
AU3038671A (OSRAM)
AU2456871A (OSRAM)
AU2486471A (OSRAM)